Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

Gemcitabine 154 Oxaliplatin 124 Fluorouracil 108 Capecitabine 105 pembrolizumab 93 Bevacizumab 79 Leucovorin 76 Irinotecan 72 Nivolumab 70 130-nm albumin-bound paclitaxel 68 Cisplatin 63 Paclitaxel 62 Cetuximab 60 Cyclophosphamide 48 Albumin-Bound Paclitaxel 45 Radiotherapy 39 Docetaxel 36 durvalumab 33 Sorafenib 32 Taxes 29 fludarabine 27 Carboplatin 27 tislelizumab 25 Drug Therapy 25 atezolizumab 23 Folfox protocol 23 regorafenib 20 lenvatinib 19 Ipilimumab 19 sintilimab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Electrochemotherapy × Gastrointestinal × Clear all

NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡